Teva Pharmaceutical Industries (NYSE:TEVA) will be posting its quarterly earnings results before the market opens on Wednesday, August 7th. Analysts expect Teva Pharmaceutical Industries to post earnings of $0.55 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
Teva Pharmaceutical Industries stock opened at $7.83 on Tuesday. Teva Pharmaceutical Industries has a fifty-two week low of $7.46 and a fifty-two week high of $25.96. The company has a debt-to-equity ratio of 1.66, a current ratio of 0.96 and a quick ratio of 0.62. The stock has a market cap of $7.97 billion, a P/E ratio of 2.80, a P/E/G ratio of 0.82 and a beta of 1.64. The firm has a 50-day moving average price of $8.49.
Several analysts have recently weighed in on the company. Argus raised Teva Pharmaceutical Industries from a “hold” rating to a “buy” rating and set a $12.00 target price for the company in a report on Friday, July 5th. ValuEngine downgraded Teva Pharmaceutical Industries from a “hold” rating to a “sell” rating in a report on Thursday, August 1st. UBS Group downgraded Teva Pharmaceutical Industries from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $22.00 to $12.00 in a research note on Tuesday, May 28th. Maxim Group reaffirmed a “hold” rating on shares of Teva Pharmaceutical Industries in a research note on Thursday, May 2nd. Finally, Cantor Fitzgerald reduced their price objective on Teva Pharmaceutical Industries from $16.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, June 12th. Six analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Teva Pharmaceutical Industries presently has an average rating of “Hold” and an average target price of $14.87.
Teva Pharmaceutical Industries Company Profile
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams.
Further Reading: Price to Earnings Ratio (PE)
Receive News & Ratings for Teva Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teva Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.